Growth Hormone Secretagogue

Posted on September 3, 2026 by pervial

Tesamorelin Clinical Evidence: Visceral Fat, Liver Health, and Metabolic Trials

3D render of a cell membrane receptor interacting with a peptide ligand to stimulate endocrine signaling.

A scientific review of clinical trial evidence evaluating tesamorelin, a growth hormone-releasing hormone analogue. We analyze human data on visceral adipo

Read more Tesamorelin Clinical Evidence: Visceral Fat, Liver Health, and Metabolic Trials

Posted on August 22, 2026 by pervial

Ipamorelin Research Peptide: Mechanism, Selectivity, and Clinical Evidence

3D molecular model representation of Ipamorelin peptide interacting with the growth hormone secretagogue receptor

A rigorous scientific breakdown of Ipamorelin, outlining its mechanism as a selective GHS-R1a agonist, preclinical and clinical trial data, and distinct en

Read more Ipamorelin Research Peptide: Mechanism, Selectivity, and Clinical Evidence

Tag: Growth Hormone Secretagogue

Tesamorelin Clinical Evidence: Visceral Fat, Liver Health, and Metabolic Trials

Ipamorelin Research Peptide: Mechanism, Selectivity, and Clinical Evidence

perVial.com